Redhill Biopharma Ltd (NASDAQ:RDHL)
| 1.05 Delayed Data As of Aug 12 |  +0.09 / +9.38%Today’s Change | 0.62 Today|||52-Week Range 11.18 | -59.30% Year-to-Date |
Latest RDHL News | Press Releases
No recent news for Redhill Biopharma Ltd.
Today’s Trading
| Previous close | 0.96 |
| Today’s open | 0.98 |
| Day’s range | 0.98 - 1.06 |
| Volume | 22,201 |
| Average volume (3 months) | 2,170,924 |
| Market cap | $54.9M |
Data as of 3:59pm ET, 08/12/2022
Growth & Valuation
| Earnings growth (last year) | -905.40% |
| Earnings growth (this year) | +96.19% |
| Earnings growth (next 5 years) | +113.00% |
| Revenue growth (last year) | +33.34% |
| P/E ratio | NM |
| Price/Sales | 1.40 |
| Price/Book | 6.08 |
Competitors
| ---- | ||
| PHASPhaseBio Pharmaceuti... | -0.02 | -1.65% |
| HEPAHepion Pharmaceutica... | -0.03 | -4.36% |
| EYENEyenovia Inc | +0.03 | +1.81% |
Data as of 3:59pm ET, 08/12/2022
Financials
| Next reporting date | August 25, 2022 |
| EPS forecast (this quarter) | -$0.02 |
| Annual revenue (last year) | $85.8M |
| Annual profit (last year) | -$97.8M |
| Net profit margin | -113.98% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters --, -- |
Forecasts
